Qingdao Vland Biotech Inc. (603739.SS) SHH
Currency In CNY
AD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 3.53B |
| Enterprise Value | 3.93B |
| P/E Ratio | 41.82 |
| PEG Ratio | 2.01 |
| Price/Sales Ratio | 2.21 |
| Price/Book Ratio | 1.72 |
| Enterprise/Revenue | 2.54 |
| Enterprise/EBITDA | 15.45 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.06 |
| Operating Margin | 0.09 |
AD
Management Effectiveness
| Return On Assets | 0.03 |
| Return On Equity | 0.04 |
Income Statement
| Revenue | 1.37B |
| Revenue/Share | 5.54 |
| Gross Profit | 611.97M |
| EBITDA | 258.27M |
| Net Income | 69.81M |
| Diluted EPS | 0.28 |
Balance Sheet
| Total Cash | 497.38M |
| Total Cash/Share | 1.97 |
| Total Debt | 700.36M |
| Total Debt/Equity | 0.39 |
| Current Ratio | 1.19 |
| Book Value Per Share | 7.61 |
Price History
| 52-Week Change | -5.12 |
| 52-Week High | 18.41 |
| 52-Week Low | 11.63 |
| Moving Average 50 Days | 14.04 |
| Moving Average 200 Days | 14.69 |
Statistics
| Average Volume | 4.33M |
| Shares Outstanding | 253.03M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0.1 |
| Trailing Annual Dividend Yield | 0.82 |
| Payout Ratio | 0.49 |
| Last Split Factor | 7:5 |
| Last Split Date | May 25, 2021 |
AD
